Navigation Links
Thomson Reuters Releases 2009 Patent Focus Report
Date:2/17/2009

Report Examines Recent Developments at Major Patenting Authorities Worldwide

PHILADELPHIA and LONDON, Feb. 18 /PRNewswire/ -- The Healthcare and Science business of Thomson Reuters today released its 2009 Patent Focus Report. Authored by Joff Wild, editor of Intellectual Asset Management magazine, and published in the Thomson Reuters KnowledgeLink(SM) eNewsletter, this report explores recent activities at each of the world's major patenting authorities (USA, Europe, Japan, China and India). The report is available free at http://go.thomsonreuters.com/pfr2009.

"The 2009 Patent Focus Report combines expert insight with the stories behind the statistics," said Tim Hamer, SVP Global Marketing Services at Thomson Reuters. "This highly anticipated report discusses the issues facing the world's major issuing authorities and dissects significant patent disputes and their outcomes."

Key findings from the 2009 Patent Focus Report include:

  • For the first time a Chinese company, Huawei Technologies Co Ltd, topped the list of Patent Co-operation Treaty applications.
  • The European Patent Office received 140,700 applications in 2007, up over 3% from the year before. In contrast, the number of patents granted fell from 62,800 in 2006 to 54,700 in 2008.
  • The number of patent examiners in India has remained relatively static - raising questions about the quality of patents coming out of the Indian IP Office. In response, at the end of 2008 India announced 414 new examiner posts to be created by 2012.
  • For the second year in a row, the Japan Patent Office reported the lowest level of approved patent applications since the mid-1990s.
  • Patent approval rates at the US Patent and Trademark Office continue to fall to below 50% of applications examined.

Published as part of the customizable KnowledgeLink eNewsletter, the 2009 Patent Focus Report draws on the expertise of Thomson Reuters specialists and guest authors, and delivers unique insight into trends in information management and cutting-edge research for information professionals, research scientists and intellectual property specialists. KnowledgeLink is distributed every two months to subscribers who can register for free and select their customized content at scientific.thomsonreuters.com/news.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kids and Their Families Are Hit Hardest During Flu Season, According to Thomson Reuters Study
2. Thomson Reuters Launches Liquent PublishPerfect(TM)
3. CMS Selects Thomson Reuters to Help Implement Medicare Medical Home Demonstration Project for Medicare Recipients
4. Thomson Reuters Installs Clinical Xpert at Catholic Healthcare West for HIS Downtime Solution
5. Thomson Reuters Publishes Three Pharma Matters Reports Covering the Third Quarter of 2008
6. Tomball Regional Medical Center Selects Clinical Xpert(TM) from Thomson Reuters to Lead Quality Improvement Initiatives
7. Thomson Reuters White Paper Explores the Role of Biomarkers in Clinical Trials and Drug Development
8. Lupus is a Significant Cost to Employers, According to Thomson Reuters Study
9. Clinical Xpert Navigator From Thomson Reuters Is Named Best Mobile Data System in the KLAS Awards - for Seventh Consecutive Year
10. BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy
11. Companies Pay a High Price for Employees With Crohns Disease and Ulcerative Colitis, According to Study From Thomson Reuters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many of ... beholder, according to experts who offered insights and commentary in the current issue of ... full issue, click here . , For the American Society of Clinical Oncology ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology: